László Vécsei MD PhD DSc
László Vécsei MD PhD DSc
University of Szeged, Faculty of Medicine, Department of Neurology
Verified email at med.u-szeged.hu
Cited by
Cited by
The epidemiology of multiple sclerosis in Europe
M Pugliatti, G Rosati, H Carton, T Riise, J Drulovic, L Vécsei, I Milanov
European journal of Neurology 13 (7), 700-722, 2006
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders
K Sas, H Robotka, J Toldi, L Vécsei
Journal of the neurological sciences 257 (1-2), 221-239, 2007
Kynurenines in the CNS: recent advances and new questions
L Vécsei, L Szalárdy, F Fülöp, J Toldi
Nature reviews Drug discovery 12 (1), 64-82, 2013
EFNS guideline on mild traumatic brain injury: report of an EFNS task force
PE Vos, L Battistin, G Birbamer, F Gerstenbrand, A Potapov, T Prevec, ...
European journal of neurology 9 (3), 207-219, 2002
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ...
Alzheimer's & Dementia 7 (4), 386-395. e6, 2011
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
The kynurenine system and immunoregulation
Y Mándi, L Vécsei
Journal of neural transmission 119 (2), 197-209, 2012
Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study
J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ...
Multiple Sclerosis Journal 21 (8), 1013-1024, 2015
Mild traumatic brain injury
PE Vos, Y Alekseenko, L Battistin, E Ehler, F Gerstenbrand, DF Muresanu, ...
European journal of neurology 19 (2), 191-198, 2012
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind†Ö
JF Howard Jr, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, ...
The Lancet Neurology 16 (12), 976-986, 2017
Role of kynurenines in the central and peripherial nervous systems
H Németh, J Toldi, L Vécsei
Current neurovascular research 2 (3), 249-260, 2005
Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis
A Pardutz, I Krizbai, S Multon, L Vecsei, J Schoenen
Neuroreport 11 (14), 3071-3075, 2000
Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients
B Tuka, Z Helyes, A Markovics, T Bagoly, J Szolcsányi, N Szabó, E Tóth, ...
Cephalalgia 33 (13), 1085-1095, 2013
Carotid stenosis and the cognitive function
LK Sztriha, D Nemeth, T Sefcsik, L Vecsei
Journal of the neurological sciences 283 (1-2), 36-40, 2009
The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection
E Vamos, A Pardutz, P Klivenyi, J Toldi, L Vecsei
Journal of the neurological sciences 283 (1-2), 21-27, 2009
Kynurenine and probenecid inhibit pentylenetetrazol-and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain
L Vécsei, J Miller, U MacGarvey, MF Beal
Brain research bulletin 28 (2), 233-238, 1992
Kynurenines, Parkinsonís disease and other neurodegenerative disorders: preclinical and clinical studies
H Nemeth, J Toldi, L Vécsei
Parkinsonís Disease and Related Disorders, 285-304, 2006
Application of a porous composite hydrophobic/hydrophilic membrane in desalination by air gap and liquid gap membrane distillation: a comparative study
M Essalhi, M Khayet
Separation and Purification Technology 133, 176-186, 2014
Huntingtonís disease: pathomechanism and therapeutic perspectives
G Gárdián, L Vécsei
Journal of neural transmission 111 (10-11), 1485-1494, 2004
The Janus-face kynurenic acid
É Rózsa, H Robotka, L Vécsei, J Toldi
Journal of Neural Transmission 115 (8), 1087-1091, 2008
The system can't perform the operation now. Try again later.
Articles 1–20